Also, the comparative effectiveness of GLP1 receptor agonists and SGLT2 inhibitors has been a growing interest, and several cohort studies with robust methodology have concluded comparable dementia risk between initiators of GLP1 receptor agonists and SGLT2 inhibitors [16, 25, 26]
Used in integrative oncology settings in conjunction with conventional cancer treatment
10.1038/cddis.2013.491 170 ParkI.KimD.KimJ.JangS.ChoiM.ChoeH
Degradation of GLP-1 The half-life of native GLP-1 in the body is approximately 12 min after the secretion owing primarily to the enzymatic degradation by dipeptidylpeptidase-4 (DPP-4) and the rapid renal elimination [56,84]
Leonov, G., Livantsova, E., Varaeva, Y